Literature DB >> 27239062

Willingness of Patients with Breast Cancer in the Adjuvant and Metastatic Setting to Use Electronic Surveys (ePRO) Depends on Sociodemographic Factors, Health-related Quality of Life, Disease Status and Computer Skills.

J Graf1, E Simoes2, K Wißlicen3, L Rava3, C B Walter3, A Hartkopf3, L Keilmann4, A Taran3, S Wallwiener3, P Fasching5, S Y Brucker6, M Wallwiener4.   

Abstract

Introduction: Because of the often unfavorable prognosis, particularly for patients with metastases, health-related quality of life is extremely important for breast cancer patients. In recent years, data on patient-relevant endpoints is being increasingly collected electronically; however, knowledge on the acceptance and practicability of, and barriers to, this form of data collection remains limited. Material and
Methods: A questionnaire was completed by 96 patients to determine to what extent existing computer skills, disease status, health-related quality of life and sociodemographic factors affect patients' potential willingness to use electronics methods of data collection (ePRO).
Results: 52 of 96 (55 %) patients reported a priori that they could envisage using ePRO. Patients who a priori preferred a paper-based survey (pPRO) tended to be older (ePRO 53 years vs. pPRO 62 years; p = 0.0014) and typically had lower levels of education (p = 0.0002), were in poorer health (p = 0.0327) and had fewer computer skills (p = 0.0003).
Conclusion: Barriers to the prospective use of ePRO were identified in older patients and patients with a lower quality of life. Given the appropriate conditions with regard to age, education and current health status, opportunities to participate should be provided to encourage patients' willingness to take part and ensure the validity of survey results. Focusing on ease of use of ePRO applications and making applications more patient-oriented and straightforward appears to be the way forward.

Entities:  

Keywords:  acceptance of technology-based surveys; breast cancer; metastatic setting; obstacles; patient-reported outcomes

Year:  2016        PMID: 27239062      PMCID: PMC4873300          DOI: 10.1055/s-0042-105872

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  35 in total

Review 1.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

2.  Patient-reported outcomes assessment in cancer trials: evaluating and enhancing the payoff to decision making.

Authors:  Steven B Clauser; Patricia A Ganz; Joseph Lipscomb; Bryce B Reeve
Journal:  J Clin Oncol       Date:  2007-11-10       Impact factor: 44.544

3.  Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.

Authors:  Jürg Bernhard; Weixiu Luo; Karin Ribi; Marco Colleoni; Harold J Burstein; Carlo Tondini; Graziella Pinotti; Simon Spazzapan; Thomas Ruhstaller; Fabio Puglisi; Lorenzo Pavesi; Vani Parmar; Meredith M Regan; Olivia Pagani; Gini F Fleming; Prudence A Francis; Karen N Price; Alan S Coates; Richard D Gelber; Aron Goldhirsch; Barbara A Walley
Journal:  Lancet Oncol       Date:  2015-06-16       Impact factor: 41.316

4.  Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies.

Authors:  Alessandra Gennari; PierFranco Conte; Riccardo Rosso; Cinzia Orlandini; Paolo Bruzzi
Journal:  Cancer       Date:  2005-10-15       Impact factor: 6.860

5.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

Review 6.  Recurrent breast cancer: treatment strategies for maintaining and prolonging good quality of life.

Authors:  Bernd Gerber; Mathias Freund; Toralf Reimer
Journal:  Dtsch Arztebl Int       Date:  2010-02-12       Impact factor: 5.594

Review 7.  Loco-regional treatment in metastatic breast cancer patients: is there a survival benefit?

Authors:  Bevan H Ly; Nam P Nguyen; Vincent Vinh-Hung; Elisabetta Rapiti; Georges Vlastos
Journal:  Breast Cancer Res Treat       Date:  2010-02       Impact factor: 4.872

8.  Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis.

Authors:  A Gondos; F Bray; T Hakulinen; H Brenner
Journal:  Ann Oncol       Date:  2008-12-09       Impact factor: 32.976

9.  Combination anastrozole and fulvestrant in metastatic breast cancer.

Authors:  Rita S Mehta; William E Barlow; Kathy S Albain; Ted A Vandenberg; Shaker R Dakhil; Nagendra R Tirumali; Danika L Lew; Daniel F Hayes; Julie R Gralow; Robert B Livingston; Gabriel N Hortobagyi
Journal:  N Engl J Med       Date:  2012-08-02       Impact factor: 91.245

10.  Metastatic breast cancer survival according to HER2 and Topo2a gene status.

Authors:  N Todorović-Raković; Z Nesković-Konstantinović; D Nikolić-Vukosavljević
Journal:  Dis Markers       Date:  2009       Impact factor: 3.434

View more
  8 in total

1.  Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry.

Authors:  Markus Wallwiener; Felix Heindl; Sara Y Brucker; Florin-Andrei Taran; Andreas Hartkopf; Friedrich Overkamp; Hans-Christian Kolberg; Peyman Hadji; Hans Tesch; Johannes Ettl; Michael P Lux; Claudia Rauh; Simon Blum; Naiba Nabieva; Tobias F Brodkorb; Cornelia Faschingbauer; Hanna Langemann; Carla Schulmeyer; Bernhard Volz; Matthias Rübner; Diana Lüftner; Volkmar Müller; Erik Belleville; Wolfgang Janni; Tanja N Fehm; Diethelm Wallwiener; Thomas Ganslandt; Matthias W Beckmann; Andreas Schneeweiss; Peter A Fasching; Paul Gass
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-08-24       Impact factor: 2.915

2.  Electronic-Based Patient-Reported Outcomes: Willingness, Needs, and Barriers in Adjuvant and Metastatic Breast Cancer Patients.

Authors:  Andreas D Hartkopf; Joachim Graf; Elisabeth Simoes; Lucia Keilmann; Nina Sickenberger; Paul Gass; Diethelm Wallwiener; Lina Matthies; Florin-Andrei Taran; Michael P Lux; Stephanie Wallwiener; Eric Belleville; Christof Sohn; Peter A Fasching; Andreas Schneeweiss; Sara Y Brucker; Markus Wallwiener
Journal:  JMIR Cancer       Date:  2017-08-07

3.  Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.

Authors:  Joachim Graf; Sara Y Brucker; Markus Wallwiener; Lina Matthies; Elisabeth Simoes; Lucia Keilmann; Andreas D Hartkopf; Alexander N Sokolov; Christina B Walter; Nina Sickenberger; Stephanie Wallwiener; Manuel Feisst; Paul Gass; Peter A Fasching; Michael P Lux; Diethelm Wallwiener; Florin-Andrei Taran; Joachim Rom; Andreas Schneeweiss
Journal:  J Med Internet Res       Date:  2017-09-14       Impact factor: 5.428

Review 4.  Are patient-reported outcomes useful in post-treatment follow-up care for women with early breast cancer? A scoping review.

Authors:  Cathrine Lundgaard Riis; Troels Bechmann; Pernille Tine Jensen; Angela Coulter; Karina Dahl Steffensen
Journal:  Patient Relat Outcome Meas       Date:  2019-03-27

5.  Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective Trial.

Authors:  Joachim Graf; Nina Sickenberger; Katharina Brusniak; Lina Maria Matthies; Thomas M Deutsch; Elisabeth Simoes; Claudia Plappert; Lucia Keilmann; Andreas Hartkopf; Christina Barbara Walter; Markus Hahn; Tobias Engler; Stephanie Wallwiener; Florian Schuetz; Peter A Fasching; Andreas Schneeweiss; Sara Yvonne Brucker; Markus Wallwiener
Journal:  J Med Internet Res       Date:  2022-02-08       Impact factor: 5.428

6.  Improving Electronic Survey Response Rates Among Cancer Center Patients During the COVID-19 Pandemic: Mixed Methods Pilot Study.

Authors:  Shelley S Tworoger; Brian D Gonzalez; Cassandra A Hathaway; Melody N Chavez; Mika Kadono; Dana Ketcher; Dana E Rollison; Erin M Siegel; Anita R Peoples; Cornelia M Ulrich; Frank J Penedo
Journal:  JMIR Cancer       Date:  2021-08-06

7.  An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study.

Authors:  Lina Maria Matthies; Florin-Andrei Taran; Joachim Graf; Markus Wallwiener; Lucia Keilmann; Andreas Schneeweiss; Elisabeth Simoes; Andreas D Hartkopf; Alexander N Sokolov; Christina B Walter; Nina Sickenberger; Stephanie Wallwiener; Manuel Feisst; Paul Gass; Michael P Lux; Florian Schuetz; Peter A Fasching; Christof Sohn; Sara Y Brucker
Journal:  J Med Internet Res       Date:  2019-01-22       Impact factor: 5.428

8.  Supporting Medical Staff from Psycho-Oncology with Smart Mobile Devices: Insights into the Development Process and First Results.

Authors:  Johannes Schobel; Madeleine Volz; Katharina Hörner; Peter Kuhn; Franz Jobst; Julian D Schwab; Nensi Ikonomi; Silke D Werle; Axel Fürstberger; Klaus Hoenig; Hans A Kestler
Journal:  Int J Environ Res Public Health       Date:  2021-05-11       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.